2,167
Views
21
CrossRef citations to date
0
Altmetric
Research Paper

Development of 3-methyl/3-(morpholinomethyl)benzofuran derivatives as novel antitumor agents towards non-small cell lung cancer cells

, , , , , , , , & show all
Pages 987-999 | Received 28 Feb 2021, Accepted 06 Apr 2021, Published online: 13 May 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Jayashree V. Patil, Shweta Umar, Rina Soni, Shubhangi S. Soman & Suresh Balakrishnan. (2023) Design, synthesis and anticancer activity of amide derivatives of substituted 3-methyl-benzofuran-2-carboxylic acid. Synthetic Communications 53:3, pages 217-233.
Read now
Ahmed A. Gaber, Mohamed Sobhy, Abdallah Turky, Hanan Gaber Abdulwahab, Ahmed A. Al-Karmalawy, Mostafa. A. Elhendawy, Mohamed. M. Radwan, Eslam B. Elkaeed, Ibrahim M. Ibrahim, Heba S. A. Elzahabi & Ibrahim H. Eissa. (2022) Discovery of new 1H-pyrazolo[3,4-d]pyrimidine derivatives as anticancer agents targeting EGFRWT and EGFRT790M. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 2283-2303.
Read now
Reda G. Yousef, Alaa Elwan, Ibraheem M. M. Gobaara, Ahmed B. M. Mehany, Wagdy M. Eldehna, Souad A. El-Metwally, Bshra A. Alsfouk, Eslam B. Elkaeed, Ahmed M. Metwaly & Ibrahim H. Eissa. (2022) Anti-cancer and immunomodulatory evaluation of new nicotinamide derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: in vitro and in silico studies. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 2206-2222.
Read now
Reda G. Yousef, Albaraa Ibrahim, Mohamed M. Khalifa, Wagdy M. Eldehna, Ibraheem M. M. Gobaara, Ahmed B. M. Mehany, Eslam B. Elkaeed, Aisha A. Alsfouk, Ahmed M. Metwaly & Ibrahim H. Eissa. (2022) Discovery of new nicotinamides as apoptotic VEGFR-2 inhibitors: virtual screening, synthesis, anti-proliferative, immunomodulatory, ADMET, toxicity, and molecular dynamic simulation studies. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 1389-1403.
Read now
Heba S. A. Elzahabi, Eman S. Nossier, Rania A. Alasfoury, May El-Manawaty, Sara M. Sayed, Eslam B. Elkaeed, Ahmed M. Metwaly, Mohamed Hagras & Ibrahim H. Eissa. (2022) Design, synthesis, and anti-cancer evaluation of new pyrido[2,3-d]pyrimidin-4(3H)-one derivatives as potential EGFRWT and EGFRT790M inhibitors and apoptosis inducers. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 1053-1076.
Read now
Longjia Yan, Qin Wang, Li Liu & Yi Le. (2022) Design, synthesis and biological evaluation of a series of dianilinopyrimidines as EGFR inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 832-843.
Read now
Mohamed Hagras, Marwa A. Saleh, Rogy R. Ezz Eldin, Abdelrahman A. Abuelkhir, Emad Gamil Khidr, Ahmed A. El-Husseiny, Hesham A. El-Mahdy, Eslam B. Elkaeed & Ibrahim H. Eissa. (2022) 1,3,4-Oxadiazole-naphthalene hybrids as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative activity, apoptotic effect, and in silico studies. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 386-402.
Read now
Mohammed M. Alanazi, Alaa Elwan, Nawaf A. Alsaif, Ahmad J. Obaidullah, Hamad M. Alkahtani, Abdulrahman A. Al-Mehizia, Sultan M. Alsubaie, Mohammed S. Taghour & Ibrahim H. Eissa. (2021) Discovery of new 3-methylquinoxalines as potential anti-cancer agents and apoptosis inducers targeting VEGFR-2: design, synthesis, and in silico studies. Journal of Enzyme Inhibition and Medicinal Chemistry 36:1, pages 1732-1750.
Read now

Articles from other publishers (13)

Xiaojing Sun, Lin Xing, Jieying Yuan, Enxiao Wang, Yuxin Ding, Ruilong Sheng, Fang Wang, Wenhui Wu, Xiuwei H. Yang & Ruihua Guo. (2023) Synthesis and biological evaluation of novel demethylzeylasteral derivatives as potential anticancer agents. Fitoterapia 167, pages 105504.
Crossref
Islam S. Marae, Raed M. Maklad, Safia Samir, Etify A. Bakhite & Walid Sharmoukh. (2023) Thieno[2,3‐c]isoquinolines: A novel chemotype of antiproliferative agents inducing cellular apoptosis while targeting the G2/M phase and Tubulin. Drug Development Research 84:4, pages 747-766.
Crossref
Tarfah Al-Warhi, Hadia Almahli, Raed M. Maklad, Zainab M. Elsayed, Mahmoud A. El Hassab, Ohoud J. Alotaibi, Nada Aljaeed, Rezk R. Ayyad, Hazem A. Ghabour, Wagdy M. Eldehna & Mohamed K. El-Ashrey. (2023) 1-Benzyl-5-bromo-3-hydrazonoindolin-2-ones as Novel Anticancer Agents: Synthesis, Biological Evaluation and Molecular Modeling Insights. Molecules 28:7, pages 3203.
Crossref
Ashraf A. Abbas & Kamal M. Dawood. (2023) Anticancer therapeutic potential of benzofuran scaffolds. RSC Advances 13:16, pages 11096-11120.
Crossref
Mohamed A Abdelgawad, Syed Nasir Abbas Bukhari, Arafa Musa, Mohammed Elmowafy, AbdElAziz A. Nayl, Ahmed H. El‐Ghorab, Mohamed Sadek Abdel-Bakky, Hany A. Omar, Nasser Hadal Alotaibi, Hossam M. Hassan, Mohammed M. Ghoneim & Rania B. Bakr. (2023) Phthalazone tethered 1,2,3-triazole conjugates: In silico molecular docking studies, synthesis, in vitro antiproliferative, and kinase inhibitory activities. Bioorganic Chemistry 133, pages 106404.
Crossref
Moustafa O. Aboelez, Moumen S. Kamel, Amany Belal, Ahmed El Badry Abdel-Aziz, Mohammed A. S. Abourehab, H. Abdel-Ghany, Mohamed A. El Hamd & Mahmoud Abd El Aleem Ali El-Remaily. (2022) Microwave-assisted synthesis, spectroscopic characterization, and biological evaluation of fused thieno[2,3-d]pyrimidines as potential anti-cancer agents targeting EGFRWT and EGFRT790M. Molecular Diversity 27:2, pages 901-917.
Crossref
Halina Kwiecień. 2023. 209 253 .
Eman S. Nossier, Rania A. Alasfoury, Mohamed Hagras, May El-Manawaty, Sara M. Sayed, Ibrahim M. Ibrahim, Hazem Elkady, Ibrahim H. Eissa & Heba S.A. Elzahabi. (2022) Modified pyrido[2,3-d]pyrimidin-4(3H)-one derivatives as EGFRWT and EGFRT790M inhibitors: Design, synthesis, and anti-cancer evaluation. Journal of Molecular Structure 1270, pages 133971.
Crossref
Tarfah Al-Warhi, Diaaeldin M. Elimam, Zainab M. Elsayed, Marwa M. Abdel-Aziz, Raed M. Maklad, Ahmed A. Al-Karmalawy, Kamyar Afarinkia, Mohammed A. S. Abourehab, Hatem A. Abdel-Aziz & Wagdy M. Eldehna. (2022) Development of novel isatin thiazolyl-pyrazoline hybrids as promising antimicrobials in MDR pathogens. RSC Advances 12:48, pages 31466-31477.
Crossref
Eslam B. Elkaeed, Reda G. Yousef, Mohamed M. Khalifa, Albaraa Ibrahim, Ahmed B. M. Mehany, Ibraheem M. M. Gobaara, Bshra A. Alsfouk, Wagdy M. Eldehna, Ahmed M. Metwaly, Ibrahim H. Eissa & Mohamed Ayman El-Zahabi. (2022) Discovery of New VEGFR-2 Inhibitors: Design, Synthesis, Anti-Proliferative Evaluation, Docking, and MD Simulation Studies. Molecules 27:19, pages 6203.
Crossref
Mansoor-Ali Vaali-Mohammed, Maha-Hamadien Abdulla, Sabine Matou-Nasri, Wagdy M. Eldehna, M. Meeramaideen, Eslam B. Elkaeed, Mohammed El-Watidy, Noura S. Alhassan, Khayal Alkhaya & Omar Al Obeed. (2022) The Anticancer Effects of the Pro-Apoptotic Benzofuran-Isatin Conjugate (5a) Are Associated With p53 Upregulation and Enhancement of Conventional Chemotherapeutic Drug Efficiency in Colorectal Cancer Cell Lines. Frontiers in Pharmacology 13.
Crossref
Reda G. Yousef, Wagdy M. Eldehna, Alaa Elwan, Abdelaziz S. Abdelaziz, Ahmed B. M. Mehany, Ibraheem M. M. Gobaara, Bshra A. Alsfouk, Eslam B. Elkaeed, Ahmed M. Metwaly & Ibrahim H. Eissa. (2022) Design, Synthesis, In Silico and In Vitro Studies of New Immunomodulatory Anticancer Nicotinamide Derivatives Targeting VEGFR-2. Molecules 27:13, pages 4079.
Crossref
Wagdy M. Eldehna, Mahmoud A. El Hassab, Nahla A. Abdelshafi, Fatma Al-Zahraa Sayed, Mohamed Fares, Sara T. Al-Rashood, Zainab M. Elsayed, Marwa M. Abdel-Aziz, Eslam B. Elkaeed, Mahmoud Elsabahy & Noura G. Eissa. (2022) Development of potent nanosized isatin-isonicotinohydrazide hybrid for management of Mycobacterium tuberculosis. International Journal of Pharmaceutics 612, pages 121369.
Crossref